Expertise in
1
conditions

Kenichi Takahashi

Akita, JP 
Expertise in
1
conditions
Akita, JP 

Overview

Kenichi Takahashi practices practicing medicine in Akita, Japan.

Mr. Takahashi is highly rated in 1 condition, according to our data. His clinical expertise encompasses Pulmonary Tuberculosis, Cerebral Hypoxia, Bile Duct Stricture, Endoscopy, and Mastectomy.

He is actively involved in clinical research, co-authoring 57 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Akita, Japan
Other Locations
Kishiwada, 5968501, Japan
Nagoya, Japan
Sendai, Japan
Iwata, Japan
Otsu, 5208511, Japan
Aomori, Japan
Ogaki, Japan
Gifu-shi, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A 52-week, Randomised, Double-blind, Double-dummy, Parallel Group, Multi-centre, Non-inferiority Study Assessing Exacerbation Rate, Additional Measures of Asthma Control and Safety in Adult and Adolescent Severe Asthmatic Participants With an Eosinophilic Phenotype Treated With GSK3511294 Compared With Mepolizumab or Benralizumab
A 52-week, Randomised, Double-blind, Double-dummy, Parallel Group, Multi-centre, Non-inferiority Study Assessing Exacerbation Rate, Additional Measures of Asthma Control and Safety in Adult and Adolescent Severe Asthmatic Participants With an Eosinophilic Phenotype Treated With GSK3511294 Compared With Mepolizumab or Benralizumab
Enrollment Status: Completed
Publish Date: May 18, 2026
Intervention Type: Biological, Drug, Device
Study Drugs: Depemokimab, Mepolizumab, Benralizumab
Study Phase: Phase 3
A 52-week, Randomised, Double-blind, Placebo-controlled, Parallel-group, Multi-centre Study of the Efficacy and Safety of GSK3511294 Adjunctive Therapy in Adult and Adolescent Participants With Severe Uncontrolled Asthma With an Eosinophilic Phenotype
A 52-week, Randomised, Double-blind, Placebo-controlled, Parallel-group, Multi-centre Study of the Efficacy and Safety of GSK3511294 Adjunctive Therapy in Adult and Adolescent Participants With Severe Uncontrolled Asthma With an Eosinophilic Phenotype
Enrollment Status: Completed
Publish Date: November 29, 2024
Intervention Type: Biological
Study Drug: Depemokimab
Study Phase: Phase 3
View 1 Less Clinical Trial

57 Total Publications

Marked Response to Nivolumab Plus Ipilimumab After the Failure of Two Prior Immune Checkpoint Inhibitor-Based Regimens Including CTLA-4 Blockade in Advanced Hepatocellular Carcinoma.
Marked Response to Nivolumab Plus Ipilimumab After the Failure of Two Prior Immune Checkpoint Inhibitor-Based Regimens Including CTLA-4 Blockade in Advanced Hepatocellular Carcinoma.
Journal: Internal medicine (Tokyo, Japan)
Published: July 20, 2026

Frequently Asked Questions about Kenichi Takahashi

Is Kenichi Takahashi a top-rated expert for Pulmonary Tuberculosis?

MediFind is an objective health platform that identifies experts based on real-world data. Kenichi Takahashi is classified as an Advanced expert for Pulmonary Tuberculosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Kenichi Takahashi participate in research or clinical trials?

Yes. Kenichi Takahashi has published 57 articles and abstracts on conditions like Pulmonary Tuberculosis. You can view a list of Kenichi Takahashi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Takahashi's expertise for a condition
ConditionClose
      View All 19 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile